IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 176 filers reported holding IVERIC BIO INC in Q4 2021. The put-call ratio across all filers is 0.12 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,969 | +16.3% | 50,050 | -28.1% | 0.01% | 0.0% |
| Q1 2023 | $1,693 | +57.9% | 69,593 | +39.0% | 0.01% | +75.0% |
| Q4 2022 | $1,072 | -99.9% | 50,050 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $898,000 | +88.3% | 50,050 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $477,000 | -43.3% | 50,050 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $842,000 | +0.6% | 50,050 | 0.0% | 0.00% | +33.3% |
| Q4 2021 | $837,000 | +3.0% | 50,050 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $813,000 | +157.3% | 50,050 | 0.0% | 0.00% | +200.0% |
| Q2 2021 | $316,000 | +2.3% | 50,050 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $309,000 | -10.7% | 50,050 | +0.1% | 0.00% | 0.0% |
| Q4 2020 | $346,000 | – | 50,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 2,914,250 | $28,035,000 | 11.91% |
| Ally Bridge Group (NY) LLC | 650,000 | $6,253,000 | 5.70% |
| Vivo Capital, LLC | 5,238,634 | $50,396,000 | 5.06% |
| COMMODORE CAPITAL LP | 2,409,961 | $23,184,000 | 4.90% |
| Finepoint Capital LP | 987,600 | $9,501,000 | 3.28% |
| ACUTA CAPITAL PARTNERS, LLC | 563,607 | $5,422,000 | 3.02% |
| Deep Track Capital, LP | 4,500,000 | $43,290,000 | 2.85% |
| Yiheng Capital Management, L.P. | 5,058,585 | $48,664,000 | 2.78% |
| Samsara BioCapital, LLC | 1,010,051 | $9,717,000 | 2.59% |
| Ghost Tree Capital, LLC | 500,000 | $4,810,000 | 2.50% |